posteditor

posteditor

/C O R R E C T I O N — Skyhawk Therapeutics/

B In the news release, Dragonfly Therapeutics Announces Encouraging Early Results from the Phase 1 for DF5112, its CCR6-Targeting Molecule, issued 18-May-2026 by Skyhawk Therapeutics… Login to continue reading Login Sign up for complimentary access Sign Up Now Close

/C O R R E C T I O N — Gentex Corporation/

B In the news release, Ops-Core, a Gentex Corporation Brand, Secures $16M Order Supporting Canadian Army Soldier Systems Program, issued 18-May-2026 by Gentex Corporation over… Login to continue reading Login Sign up for complimentary access Sign Up Now Close